Texas Workforce Commission documents reviewed by the Houston Chronicle show 161 people will be permanently laid off due to the closures. The layoffs were set to begin March 1.
In a statement to the Houston Chronicle, OptumRx said: “Following a review of Avella’s business, we decided to discontinue performing drug compounding services at our Houston locations. Avella’s core products and solutions remain an important part of our efforts to improve health outcomes and experiences for consumers while reducing overall healthcare costs.”
More articles on pharmacy:
10 hospitals seeking pharmacy leadership
Patent protection clause is latest stumbling block for revised NAFTA
Dr. Reddy’s legal win expected to lower cost of opioid addiction treatment
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.